JP5805477B2 - Baked confectionery containing branched chain amino acids - Google Patents
Baked confectionery containing branched chain amino acids Download PDFInfo
- Publication number
- JP5805477B2 JP5805477B2 JP2011206430A JP2011206430A JP5805477B2 JP 5805477 B2 JP5805477 B2 JP 5805477B2 JP 2011206430 A JP2011206430 A JP 2011206430A JP 2011206430 A JP2011206430 A JP 2011206430A JP 5805477 B2 JP5805477 B2 JP 5805477B2
- Authority
- JP
- Japan
- Prior art keywords
- baked confectionery
- starch
- branched chain
- chain amino
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000009508 confectionery Nutrition 0.000 title claims description 69
- 150000005693 branched-chain amino acids Chemical class 0.000 title claims description 25
- 229920002472 Starch Polymers 0.000 claims description 31
- 230000014759 maintenance of location Effects 0.000 claims description 28
- 235000019698 starch Nutrition 0.000 claims description 26
- 239000008107 starch Substances 0.000 claims description 26
- 150000002632 lipids Chemical class 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 11
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 10
- 229960000310 isoleucine Drugs 0.000 claims description 10
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 9
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 9
- 235000013312 flour Nutrition 0.000 claims description 9
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 9
- 229960003136 leucine Drugs 0.000 claims description 9
- 229960004295 valine Drugs 0.000 claims description 9
- 239000004474 valine Substances 0.000 claims description 9
- 240000003183 Manihot esculenta Species 0.000 claims description 7
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 229920002261 Corn starch Polymers 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 5
- 229920001592 potato starch Polymers 0.000 claims description 3
- 229940100486 rice starch Drugs 0.000 claims description 3
- 239000002994 raw material Substances 0.000 description 18
- 235000013305 food Nutrition 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 15
- 235000016709 nutrition Nutrition 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000000835 fiber Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- -1 (MPC) Proteins 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 235000021552 granulated sugar Nutrition 0.000 description 8
- 235000013325 dietary fiber Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000010304 firing Methods 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 108010068370 Glutens Proteins 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 108010011756 Milk Proteins Proteins 0.000 description 3
- 102000014171 Milk Proteins Human genes 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000021312 gluten Nutrition 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 235000013310 margarine Nutrition 0.000 description 3
- 239000003264 margarine Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000021239 milk protein Nutrition 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 102000011632 Caseins Human genes 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000021120 animal protein Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000011903 nutritional therapy Methods 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000005486 organic electrolyte Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 210000003019 respiratory muscle Anatomy 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000000112 undernutrition Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- AOFUBOWZWQFQJU-SNOJBQEQSA-N (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-2,3,4-triol;(2s,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O AOFUBOWZWQFQJU-SNOJBQEQSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- HYCSHFLKPSMPGO-UHFFFAOYSA-N 3-hydroxypropyl dihydrogen phosphate Chemical compound OCCCOP(O)(O)=O HYCSHFLKPSMPGO-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MKRNVBXERAPZOP-UHFFFAOYSA-N Starch acetate Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OC(C)=O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 MKRNVBXERAPZOP-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013804 distarch phosphate Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229910001392 phosphorus oxide Inorganic materials 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical class [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Confectionery (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Description
本発明は、手軽に分岐鎖アミノ酸およびエネルギーを摂取することができる、病者向けの総合栄養食品に関する。 The present invention relates to a comprehensive nutritional food for patients who can easily take branched chain amino acids and energy.
高齢の有病患者の運動栄養において、慢性閉塞性肺疾患(COPD)や骨折時のリハビリテーションの際の栄養介入がない場合、体重減少などの低栄養のリスクが高くなるが、総合栄養食品の摂取によって低栄養のリスクを少なくすることが知られている。このような患者の多くは食欲不振を伴うため、通常の食事に加えて補食として、総合栄養食品を摂取することが好ましい。(非特許文献1) If there is no nutritional intervention during chronic obstructive pulmonary disease (COPD) or rehabilitation at the time of fracture, the risk of undernutrition such as weight loss is high in exercise nutrition of elderly patients, but intake of comprehensive nutritional foods Is known to reduce the risk of undernutrition. Since many of these patients have anorexia, it is preferable to take a comprehensive nutritional food as a supplement in addition to a normal meal. (Non-Patent Document 1)
特に、COPD患者において、症状および障害の進行とともに体重が減少することが知られている。体重減少のある患者は、体重減少のない患者に比べ有意に生存率が低くなるため、積極的な栄養療法が実施される。その栄養療法においては、呼吸商の低い脂質を主体とし、呼吸筋のタンパク合成促進作用や異化抑制作用があるイソロイシン、ロイシンおよびバリンの3種類の分岐鎖アミノ酸の摂取が推奨されている。(非特許文献2) In particular, it is known that body weight decreases with progression of symptoms and disability in COPD patients. Patients with weight loss have a significantly lower survival rate than patients without weight loss, so aggressive nutritional therapy is implemented. In the nutritional therapy, intake of three types of branched chain amino acids, ie, isoleucine, leucine and valine, which are mainly composed of lipids having a low respiratory quotient and have a respiratory muscle protein synthesis promoting action and a catabolic inhibitory action, is recommended. (Non-Patent Document 2)
また、COPD患者は、換気障害に基づく呼吸筋酸素消費量の増大によって必要エネルギー量が増加しているにもかかわらず、息切れや肺の過膨張により、食欲低下や腹部膨満感を伴っており、いかにして、少量で効率良く食べるかを工夫することが必要である。(非特許文献3) In addition, COPD patients are accompanied by a decrease in appetite and abdominal fullness due to shortness of breath and hyperinflation of the lungs, despite an increase in the amount of energy required due to an increase in respiratory muscle oxygen consumption based on ventilation disorders. It is necessary to devise how to eat efficiently in small amounts. (Non Patent Literature 3)
しかしながら、これまでに一般的に用いられている総合栄養食品には分岐鎖アミノ酸は十分に配合されておらず、また液状、ゲル状、ゾル状または、粉末を水に溶解して飲用するタイプが主流であり、摂取エネルギーに対する容量が多く、腹部膨満感が増大するため、COPD患者のような病者に適したものとは言えなかった。 However, branched-chain amino acids are not sufficiently blended in general nutrition foods that have been generally used so far, and liquid, gel-like, sol-like, or powder-types that can be taken by dissolving in water are available. Since it is mainstream and has a large capacity for intake energy and abdominal fullness increases, it cannot be said that it is suitable for a sick person such as a COPD patient.
以上の状況に鑑み、食欲低下や腹部膨満感を伴う患者が摂取しやすいような形態の総合栄養食品を検討した結果、本発明者らは、分岐鎖アミノ酸を配合した高エネルギーの焼菓子形態が最適であると考えた。しかし、このような焼菓子を調製する場合、脂質エネルギー比を高く、容量が小さくなるように配合を調整しなければならない。その結果、焼菓子の骨格となるグルテンを含む小麦粉や、たんぱく原料、あるいは食物繊維を十分に配合することができないといった問題があった。 In view of the above situation, as a result of studying a comprehensive nutritional food in a form that is easy for a patient with decreased appetite and abdominal fullness, the present inventors have found that a high energy baked confectionery form containing a branched chain amino acid is present. I thought it was optimal. However, when preparing such baked confectionery, the formulation must be adjusted so that the lipid energy ratio is high and the volume is small. As a result, there has been a problem that the flour containing gluten serving as the skeleton of the baked confectionery, the protein raw material, or the dietary fiber cannot be blended sufficiently.
更に、生地中の油脂や分岐鎖アミノ酸が、小麦粉に含まれるグルテンの骨格形成能を阻害するため、通常の焼菓子の調製方法では、焼成前後の保形性および焼成後に食品として好ましい硬さを付与することができないといった問題があった。 Furthermore, because fats and oils and branched chain amino acids in the dough hinder the ability of the gluten contained in the flour to form a skeleton, the usual method for preparing baked confectionery has shape retention before and after baking and preferable hardness as a food after baking. There was a problem that it could not be granted.
本発明の目的は、上述の状況を鑑みてなされたもので、COPD患者等、食欲が低下し、腹部膨満感を伴う患者の栄養状態を改善するものであり、高脂質でかつ分岐鎖アミノ酸を含む焼菓子形態の分岐鎖アミノ酸含有総合栄養食品を提供するものである。 The object of the present invention has been made in view of the above situation, and is intended to improve the nutritional status of patients with COPD patients who have decreased appetite and abdominal bloating, and have high lipid and branched chain amino acids. The present invention provides a comprehensive nutritional food containing branched chain amino acids in the form of baked confectionery.
本発明者らは、前記目的を達成すべく、鋭意研究を重ねた結果、分岐鎖アミノ酸として、イソロイシン、ロイシンおよびバリンを合計1.0〜4.0 g/100 kcal、脂質を35〜50エネルギー%含有する焼菓子において、保形用にデンプン所定量を含有することにより、焼成前後に保形性を有し、さらに焼成後も適度な固さを保つことができる焼菓子を製造できることを見出した。 As a result of intensive studies to achieve the above object, the inventors of the present invention have a total of 1.0 to 4.0 g / 100 kcal of isoleucine, leucine and valine as branched chain amino acids, and 35 to 50 energies of lipids. In the baked confectionery containing 1%, it has been found that by containing a predetermined amount of starch for shape retention, it is possible to produce a baked confectionery that has shape retention before and after baking and can maintain an appropriate hardness even after baking. It was.
すなわち、本発明は以下の(1)〜(3)に示したものである。
(1)分岐鎖アミノ酸として、イソロイシン、ロイシンおよびバリンを合計1.0〜4.0 g/100 kcal、脂質を35〜50エネルギー%含有し、さらに、ワキシーコーンデンプン、タピオカデンプン、もち米デンプン、馬鈴薯デンプンから選ばれる少なくとも1種を分岐鎖アミノ酸1重量部に対して0.1〜1.2重量部、及び小麦粉を含有し、焼成後の保形性が1.0〜1.15であり、焼成後の硬さが20〜80Nである焼菓子。
(2)イソロイシン、ロイシンおよびバリンの配合割合が1:1.8〜2.2:0.9〜1.1である(1)に記載の焼菓子。
(3)さらに、ビタミンまたはミネラルが配合されてなる(1)または(2)に記載の焼菓子。
That is, this invention is shown to the following (1)- (3) .
(1) As branched chain amino acids, isoleucine, leucine and valine are added in a total of 1.0 to 4.0 g / 100 kcal, lipid is contained in 35 to 50 energy%, and waxy corn starch, tapioca starch, glutinous rice starch, At least one selected from potato starch contains 0.1 to 1.2 parts by weight with respect to 1 part by weight of branched chain amino acids , and flour, and the shape retention after baking is 1.0 to 1.15. A baked confectionery having a hardness of 20 to 80 N after baking.
( 2 ) The baked confectionery according to (1) , wherein the blending ratio of isoleucine, leucine and valine is 1: 1.8 to 2.2: 0.9 to 1.1.
( 3 ) The baked confectionery according to (1) or (2) , further comprising a vitamin or a mineral.
本発明の焼菓子は、分岐鎖アミノ酸を含有し、かつ脂質を多く含有するにもかかわらず、焼成前後に保形性を有し、さらに焼成後も適度な硬さを保つことができる。そのため、上記のCOPD患者等のような、食欲が低下し、腹部膨満感を伴う患者でも、効果的に分岐鎖アミノ酸が補給できる総合栄養食品を提供することができる。 Although the baked confectionery of the present invention contains branched chain amino acids and contains a large amount of lipid, the baked confectionery has shape retention before and after baking, and can maintain an appropriate hardness even after baking. Therefore, it is possible to provide a comprehensive nutritional food that can effectively replenish branched chain amino acids even in patients with decreased appetite and abdominal fullness, such as the above-mentioned COPD patients.
以下、本発明の焼菓子を詳細に説明する。
本発明に示される「焼菓子」とは、生地を賦型後、加熱焼成して成形したものを意味する。生地に使用する原料は、従来焼菓子を調製する際に使用されているものはいずれも可能であり、例えば、小麦粉、糖類、食用油脂を主原料とし、必要に応じて食塩、乳製品、卵、膨張剤などを加えたものである。この目的に合致する焼菓子に属するものの代表例としては、クッキー類、ビスケット類、サブレ類などを挙げることができる。
Hereinafter, the baked confectionery of the present invention will be described in detail.
The “baked confectionery” shown in the present invention means a material obtained by shaping a dough and then heating and baking it. The raw materials used for the dough can be any of those conventionally used when preparing baked confectionery. For example, flour, sugar, edible oils and fats are the main ingredients, and if necessary, salt, dairy products, eggs In addition, a swelling agent is added. Representative examples of those belonging to the baked confectionery that meet this purpose include cookies, biscuits, and sachets.
本明細書において、「保形性」は、7mm厚の均一な板状に伸ばした生地を、直径6cmの円形型により型抜きし、円盤状に成形された生地を上から見た場合の、焼成前の投影面積に対する焼成後の投影面積の比により判断される。 In the present specification, “shape retention” means that a dough stretched into a uniform plate shape having a thickness of 7 mm is cut out by a circular mold having a diameter of 6 cm, and the dough formed into a disk shape is viewed from above. This is determined by the ratio of the projected area after firing to the projected area before firing.
また、本明細書において、「硬さ」は、生地を一定の厚さの均一な板状に伸ばした生地を、直径5.5〜8cmの型により型抜きし、円盤状に成型された生地をオーブン等で焼成して得た該焼菓子を、クリープメーター(MODEL RHEONER2、株式会社山電)を用いて、破断強度試験を行った場合の「最大荷重」により判断される。 In the present specification, “hardness” refers to a dough obtained by punching out a dough obtained by stretching the dough into a uniform plate shape having a constant thickness with a die having a diameter of 5.5 to 8 cm, and then forming it into a disk shape. This baked confectionery obtained by baking in an oven or the like is judged by the “maximum load” when a rupture strength test is conducted using a creep meter (MODEL RHEONER2, Yamaden Co., Ltd.).
本発明の焼菓子に使用する分岐鎖アミノ酸とは、イソロイシン、ロイシンおよびバリンであり、本発明の焼菓子におけるこれらの分岐鎖アミノ酸の配合量は、100kcalあたり1.0〜4.0gの範囲である。分岐鎖アミノ酸の配合量が、1.0gより少ないと、目的とする分岐鎖アミノ酸量を摂取できなくなり、好ましくない。また、4.0gを越えると、焼成後の焼菓子が十分な保形性および硬さを有さなくなり、食品として好ましくない。また、イソロイシン、ロイシンおよびバリンの配合割合は特に限定されないが、栄養学的なバランスを考慮すると、1:1.8〜2.2:0.9〜1.1であることが好ましい。この配合割合は、体たんぱく質合成にとって最適な比率に近く、ヒトの母乳中に含まれる分岐鎖アミノ酸の割合にも近い。 The branched chain amino acids used in the baked confectionery of the present invention are isoleucine, leucine and valine, and the blended amount of these branched chain amino acids in the baked confectionery of the present invention is in the range of 1.0 to 4.0 g per 100 kcal. is there. When the blended amount of the branched chain amino acid is less than 1.0 g, the target branched chain amino acid amount cannot be taken, which is not preferable. On the other hand, if it exceeds 4.0 g, the baked confectionery after baking does not have sufficient shape retention and hardness, which is not preferable as a food. Further, the blending ratio of isoleucine, leucine and valine is not particularly limited, but is preferably 1: 1.8 to 2.2: 0.9 to 1.1 in consideration of nutritional balance. This blending ratio is close to the optimum ratio for body protein synthesis and close to the ratio of branched chain amino acids contained in human breast milk.
本発明の焼菓子には、本発明の主旨を逸脱しない範囲内で、従来から食品に慣用されるたんぱく質原料を配合してもよい。植物性たんぱく質原料として、例えば、大豆たんぱく、濃縮大豆たんぱく、小麦たんぱく、コーングルテンミールなどが例示できる。また、動物性たんぱく質原料として、例えば、牛乳、脱脂乳などの乳製品の他、カゼイン、カゼインナトリウム、カゼインマグネシウム、カゼインカルシウム、乳清、トータル・ミルク・プロテイン(TMP)、ミルク・プロテイン・コンセントレート(MPC)などの乳たんぱく、卵白、コラーゲン、プロタミンなどを例示することができる。 The baked confectionery of the present invention may be blended with a protein raw material conventionally used in foods without departing from the gist of the present invention. Examples of vegetable protein materials include soy protein, concentrated soy protein, wheat protein, corn gluten meal, and the like. In addition to dairy products such as milk and skim milk, examples of animal protein ingredients include casein, sodium caseinate, magnesium caseinate, calcium caseinate, whey, total milk protein (TMP), and milk protein concentrate. Examples thereof include milk proteins such as (MPC), egg white, collagen, protamine and the like.
たんぱく質を配合する場合、たんぱく質の割合は、5〜20エネルギー%、好ましくは10〜15エネルギー%の範囲である。たんぱく質の割合が、5エネルギー%より少ないと、目的とするたんぱく質量を摂取できなくなり、好ましくない。また、20エネルギー%を越えると、脂質エネルギーを摂取できなくなり、好ましくない。 When the protein is blended, the ratio of the protein is in the range of 5 to 20 energy%, preferably 10 to 15 energy%. If the ratio of the protein is less than 5 energy%, the target protein mass cannot be taken, which is not preferable. Moreover, when it exceeds 20 energy%, it becomes impossible to take in lipid energy, and is unpreferable.
本発明の焼菓子は、保形性を付与するためにデンプンを含有する。本発明において、デンプンとは、デンプン質原料となる植物の子実や塊茎、根茎に存在している、アミロースまたはアミロペクチンから成る高分子化合物であり、工業的に利用しやすいように、分離、精製したもの、またはそれらに修飾を加えたものを指す。 The baked confectionery of the present invention contains starch in order to impart shape retention. In the present invention, starch is a polymer compound composed of amylose or amylopectin, which is present in the seeds, tubers, and rhizomes of plants that are starchy raw materials, and is separated and purified so that it can be easily used industrially. Or those with modifications.
含有するデンプンとして、ワキシーコーンデンプン、タピオカデンプン、もち米デンプン、馬鈴薯デンプンから少なくとも1種以上を使用すると、焼成後の固さを十分に保つことができる。 As starch containing, waxy corn starch, tapioca starch, glutinous rice starch, the use of at least one kind from potato starch, can be kept firmness after firing sufficiently.
本発明の焼菓子に配合するデンプンの配合量は、分岐鎖アミノ酸1重量部に対して0.1〜1.2重量部である。デンプンの配合量が0.1重量部より少ないと、焼成後の焼菓子が十分な硬さと保形性を有さなくなり、食品として好ましくない。また、1.2重量部を超えると、焼成品の水分量が多くなり、長期保存に適さなくなり好ましくない。 The compounding quantity of the starch mix | blended with the baked confectionery of this invention is 0.1-1.2 weight part with respect to 1 weight part of branched chain amino acids. When the blending amount of starch is less than 0.1 parts by weight, the baked confectionery after baking does not have sufficient hardness and shape retention, which is not preferable as a food. On the other hand, if the amount exceeds 1.2 parts by weight, the amount of water in the fired product increases, which is not suitable for long-term storage.
本発明の焼菓子に配合する脂質としては、従来から食品で利用されている公知の各種の食用油脂類が、1種単独でまたは2種以上混合して使用できる。例えば、アマニ油、エゴマ油、オリーブ油、ゴマ油、米油、米糠油、サフラワー油、シソ油、大豆油、コーン油、ナタネ油、胚芽油、パーム油、パーム核油、ヒマワリ油、綿実油、ヤシ油、ナッツ油、落花生油、カカオ脂などの植物性油脂やラード、牛脂、魚油、乳脂などの動物性油脂、中鎖脂肪酸、高度不飽和脂肪酸、DHA、EPA、ジアシルグリセロールなどの加工油脂、また、これら油脂を含有するバター、マーガリン、ショートニングなどの油脂加工品などが挙げられる。 As the lipid to be blended in the baked confectionery of the present invention, various known edible fats and oils that have been conventionally used in foods can be used singly or in combination of two or more. For example, linseed oil, sesame oil, olive oil, sesame oil, rice oil, rice bran oil, safflower oil, perilla oil, soybean oil, corn oil, rapeseed oil, germ oil, palm oil, palm kernel oil, sunflower oil, cottonseed oil, palm Vegetable oils such as oil, nut oil, peanut oil, cocoa butter, animal oils such as lard, beef tallow, fish oil, milk fat, medium chain fatty acids, highly unsaturated fatty acids, processed oils such as DHA, EPA, diacylglycerol, And fats and oils processed products such as butter, margarine and shortening containing these fats and oils.
本発明の焼菓子中の脂質の割合は、35〜50エネルギー%、好ましくは40〜50エネルギー%の範囲である。脂質の割合が、35エネルギー%より少なくなると、目的とするエネルギーを脂質として摂取できなくなり、好ましくない。また、50エネルギー%より多くなると、十分なタンパク質量が摂取できなくなり、好ましくない。ここで、エネルギー%とは、本発明の焼菓子の総エネルギーに対する脂質由来のエネルギーの比を百分率で表した数値である。 The ratio of the lipid in the baked confectionery of this invention is 35-50 energy%, Preferably it is the range of 40-50 energy%. If the proportion of lipid is less than 35 energy%, the target energy cannot be taken in as lipid, which is not preferable. Moreover, when it exceeds 50 energy%, it will become impossible to ingest sufficient protein amount, and is unpreferable. Here, energy% is a numerical value representing the ratio of the energy derived from lipid to the total energy of the baked confectionery of the present invention as a percentage.
本発明の焼菓子は、さらにデンプン以外の糖質を含有することが好ましい。糖質としては、従来から食品で利用されてきている公知の各種のもののいずれも使用できる、例えば、ブドウ糖(グルコース)、乳糖(ラクトース)、果糖(フルクトース)などの単糖類、蔗糖、グラニュー糖、麦芽糖、トレハロース、マルトース、イソマルトースなどの二糖類、グリコーゲン、デキストリン(デンプンが熱、酸、酵素その他の作用によって分解された種々の分解生成物)や、水飴、還元水飴、はちみつ、異性化糖、転化糖、オリゴ糖(イソマルトオリゴ糖、還元キシロオリゴ糖、還元ゲンチオオリゴ糖、キシロオリゴ糖、ゲンチオオリゴ糖、ニゲロオリゴ糖、テアンデオリゴ糖、大豆オリゴ糖など)、粉飴、糖アルコール(マルチトール、エリスリトール、ソルビトール、パラチニット、キシリトール、ラクチトールなど)、砂糖結合水飴(カップリングシュガー)などが挙げられる。これらは1種用いてもよいし、2種以上を組み合わせてもよい。前述の脂質およびたんぱく質のエネルギー%に関する記載から明らかな通り、本発明の焼菓子の糖質は30〜60エネルギー%であるので、これら甘味成分の配合には糖質のエネルギー%に留意して配合する必要がある。 The baked confectionery of the present invention preferably further contains a saccharide other than starch. As the saccharide, any of various known substances that have been conventionally used in foods can be used, for example, monosaccharides such as glucose (glucose), lactose (lactose), fructose (fructose), sucrose, granulated sugar, Maltose, trehalose, maltose, isomaltose and other disaccharides, glycogen, dextrin (various degradation products of starch decomposed by heat, acid, enzyme and other actions), starch syrup, reduced starch syrup, honey, isomerized sugar, Invert sugar, oligosaccharide (isomalto-oligosaccharide, reduced xylo-oligosaccharide, reduced gentio-oligosaccharide, xylo-oligosaccharide, gentio-oligosaccharide, nigero-oligosaccharide, theande-oligosaccharide, soybean oligosaccharide, etc.) flour, sugar alcohol (maltitol, erythritol, sorbitol, paratinite , Xylitol, lactitol, etc. , Sugar-binding syrup (coupling sugar), and the like. These may be used alone or in combination of two or more. As is apparent from the above description regarding the energy percentage of lipids and proteins, the sugar content of the baked confectionery of the present invention is 30 to 60 energy%. Therefore, the sweetener component is formulated with attention to the sugar energy percentage. There is a need to.
また、従来公知もしくは将来知られうる甘味成分も糖類の代わりに用いることができ、具体的には、アスパルテーム、アセスルファムカリウム、スクラロース、アリテーム、ネオテーム、カンゾウ抽出物(グリチルリチン)、サッカリン、サッカリンナトリウム、ステビア抽出物、ステビア末などが挙げられる。 In addition, conventionally known or future known sweetening ingredients can also be used in place of sugars, specifically, aspartame, acesulfame potassium, sucralose, alitame, neotame, licorice extract (glycyrrhizin), saccharin, saccharin sodium, stevia extract Products, stevia powder, etc.
本発明の焼菓子は、本発明の主旨を逸脱しない範囲内で、食物繊維を配合してもよい。例えば、グアーガム酵素分解物、低分子化アルギン酸ナトリウム、グルコマンナン、イヌリン、リンゴ食物繊維などの水溶性食物繊維やコーンファイバー、レジスタントスターチ、サイリウム種皮、ビートファイバー、アップルファイバー、サトウキビ食物繊維、小麦ふすま、発酵大麦ファイバー、エンドウファイバー、夕顔果実食物繊維、シトラスファイバー、セルロース、小麦ファイバー、オート麦ファイバー、ポテトファイバー、大豆ファイバーなどの不溶性食物繊維が挙げられる。 The baked confectionery of this invention may mix | blend dietary fiber within the range which does not deviate from the main point of this invention. For example, water-soluble dietary fiber such as guar gum enzyme degradation product, low molecular weight sodium alginate, glucomannan, inulin, apple dietary fiber, corn fiber, resistant starch, psyllium seed coat, beet fiber, apple fiber, sugarcane dietary fiber, wheat bran And insoluble dietary fiber such as fermented barley fiber, pea fiber, evening fruit fruit dietary fiber, citrus fiber, cellulose, wheat fiber, oat fiber, potato fiber, soybean fiber and the like.
本発明の焼菓子を製造する際には、製品の種類に応じて通常用いられる適当なビタミン類やミネラル類などの成分を配合することが出来る。
本発明の焼菓子に用いるビタミン類としては、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、ナイアシン、パントテン酸、葉酸、ビオチン、ビタミンC、ビタミンA、ビタミンD、ビタミンE、ビタミンKなどが挙げられ、これら複数をできる限り組み合わせて配合するのが、栄養学的観点から好ましい。ビタミンとしては、ビタミン誘導体を使用してもよい。
When manufacturing the baked confectionery of this invention, components, such as suitable vitamins and minerals normally used according to the kind of product, can be mix | blended.
The vitamins used in the baked confectionery of the present invention include vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, pantothenic acid, folic acid, biotin, vitamin C, vitamin A, vitamin D, vitamin E, vitamin K, and the like. From the nutritional viewpoint, it is preferable to combine a plurality of these as much as possible. A vitamin derivative may be used as the vitamin.
ビタミンの配合量としては、焼菓子100kcalあたり、下記の範囲が適当である。
ビタミンB1 0.1〜40mg、好ましくは0.3〜25mg
ビタミンB2 0.1〜20mg、好ましくは0.33〜12mg
ビタミンB6 0.1〜60mg、好ましくは0.3〜10mg
ビタミンB12 0.1〜100μg、好ましくは0.60〜60μg
ナイアシン 1〜300mg、好ましくは3.3〜60mg
パントテン酸 0.1〜55mg、好ましくは1.65〜30mg
葉酸 10〜1000μg、好ましくは60〜200μg
ビオチン 1〜1000μg、好ましくは14〜500μg
ビタミンC 10〜2000mg、好ましくは24〜1000mg
ビタミンA 0〜3000μg、好ましくは135〜600μg
ビタミンD 0.1〜50μg、好ましくは1.5〜5.0μg
ビタミンE 1〜800mg、好ましくは2.4〜150mg
ビタミンK 0.5〜1000μg、好ましくは2〜700μg
As the amount of vitamins, the following range is appropriate per 100 kcal of baked confectionery.
Vitamin B1 0.1-40 mg, preferably 0.3-25 mg
Vitamin B2 0.1-20 mg, preferably 0.33-12 mg
Vitamin B6 0.1-60 mg, preferably 0.3-10 mg
Vitamin B12 0.1-100 μg, preferably 0.60-60 μg
Niacin 1-300 mg, preferably 3.3-60 mg
Pantothenic acid 0.1-55 mg, preferably 1.65-30 mg
Folic acid 10-1000 μg, preferably 60-200 μg
Biotin 1-1000 μg, preferably 14-500 μg
Vitamin C 10-2000 mg, preferably 24-1000 mg
Vitamin A 0-3000 μg, preferably 135-600 μg
Vitamin D 0.1-50 μg, preferably 1.5-5.0 μg
Vitamin E 1-800 mg, preferably 2.4-150 mg
Vitamin K 0.5-1000 μg, preferably 2-700 μg
本発明の焼菓子に用いるミネラル類として、ナトリウム、カリウム、カルシウム、マグネシウム、リンおよび亜鉛などが挙げられ、これら複数をできる限り組み合わせて配合するのが栄養学的観点から好ましい。これらは、無機電解質成分として配合されていても良いし、有機電解質成分、として配合されていてもよい。無機電解質成分としては、例えば、塩化物、硫酸化物、炭酸化物、リン酸化物などのアルカリ金属またはアルカリ土類金属の塩類が挙げられる。また、有機電解質成分としては、有機酸、例えばクエン酸、乳酸、アミノ酸(例えば、グルタミン酸、アスパラギン酸など)、アルギン酸、リンゴ酸またはグルコン酸と、無機塩基、例えばアルカリ金属またはアルカリ土類金属との塩類が挙げられる。例えば、塩化カルシウム、クエン酸カルシウム、グリセロリン酸カルシウム、グルコン酸カルシウム、水酸化カルシウム、ステアリン酸カルシウム、ステアロイル乳酸カルシウム、炭酸カルシウム、乳酸カルシウム、ピロリン酸二水素カルシウム、硫酸カルシウム、リン酸三カルシウム、リン酸一水素カルシウム、リン酸二水素カルシウム、未焼成カルシウム、塩化マグネシウム、ステアリン酸マグネシウム、炭酸マグネシウム、硫酸マグネシウム、リン酸三マグネシウム、グルコン酸亜鉛、硫酸亜鉛などが挙げられる。 Examples of the minerals used in the baked confectionery of the present invention include sodium, potassium, calcium, magnesium, phosphorus and zinc, and it is preferable from the nutritional viewpoint to combine these plural combinations as much as possible. These may be mix | blended as an inorganic electrolyte component, and may be mix | blended as an organic electrolyte component. Examples of the inorganic electrolyte component include alkali metal or alkaline earth metal salts such as chlorides, sulfates, carbonates, and phosphorus oxides. The organic electrolyte component includes an organic acid such as citric acid, lactic acid, amino acid (such as glutamic acid and aspartic acid), alginic acid, malic acid or gluconic acid and an inorganic base such as an alkali metal or alkaline earth metal. Examples include salts. For example, calcium chloride, calcium citrate, calcium glycerophosphate, calcium gluconate, calcium hydroxide, calcium stearate, calcium stearoyl lactate, calcium carbonate, calcium lactate, dihydrogen pyrophosphate, calcium sulfate, tricalcium phosphate, monophosphate Examples include calcium hydrogen, calcium dihydrogen phosphate, uncalcined calcium, magnesium chloride, magnesium stearate, magnesium carbonate, magnesium sulfate, trimagnesium phosphate, zinc gluconate, and zinc sulfate.
ミネラルの配合量としては、焼菓子100kcalあたり、下記の範囲が適当である。
ナトリウム 5〜6000mg、好ましくは10〜3500mg
カリウム 1〜3500mg、好ましくは25〜1800mg
マグネシウム 1〜740mg、好ましくは25〜300mg
カルシウム 10〜2300mg、好ましくは250〜600mg
リン 1〜3500mg、好ましくは25〜1500mg
亜鉛 0.1〜30mg、好ましくは1〜15mg
As the blending amount of the mineral, the following range is appropriate per 100 kcal of baked confectionery.
Sodium 5-6000mg, preferably 10-3500mg
Potassium 1-3500 mg, preferably 25-1800 mg
Magnesium 1-740 mg, preferably 25-300 mg
Calcium 10-2300 mg, preferably 250-600 mg
Phosphorus 1-3500 mg, preferably 25-1500 mg
Zinc 0.1-30mg, preferably 1-15mg
本発明の焼菓子は、前記主成分の他に、必要に応じて、栄養価を高めたり、風香味を付与したり、着色したりする目的で用いられる種々の添加物を更に含有することができる。該添加物としては、例えば、風香味付与を目的とする香料(合成香料および天然香料)、醤油、味噌、化学調味料、風味物質(チーズ、チョコレート、ココアパウダーなど)など、着色を目的とするカラメル、天然着色料など、その他、乳化剤(グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、プロピレングリコール脂肪酸エステル、ショ糖脂肪酸エステル、レシチンなど)、安定剤、防腐剤などをそれぞれ挙げることができる。これらの添加剤はそれぞれ1種単独でも2種以上組み合わせても利用することができる。 In addition to the main component, the baked confectionery of the present invention may further contain various additives used for the purpose of increasing nutritional value, imparting flavor, or coloring, as necessary. it can. Examples of the additive include coloring for flavoring (synthetic flavoring and natural flavoring) for imparting flavor, soy sauce, miso, chemical seasoning, flavoring substances (cheese, chocolate, cocoa powder, etc.), and the like. Other examples include caramel, natural colorants, and other emulsifiers (glycerin fatty acid ester, sorbitan fatty acid ester, propylene glycol fatty acid ester, sucrose fatty acid ester, lecithin, etc.), stabilizers, preservatives, and the like. These additives can be used either individually or in combination of two or more.
なお、本発明の焼菓子には、食塩、イースト、酵素、膨張剤などを必要に応じて添加することもできる。酵素としては、例えば、製菓用に一般によく知られている各種のプロテアーゼ、アミラーゼ、セルラーゼなどを例示することができる。膨張剤としては、食品業界で汎用されている、例えば炭酸水素ナトリウム、炭酸水素アンモニウムなどおよびこれらを含むものを例示することができる。その代表例としては市販のベーキングパウダーを例示することができる。これら食塩、イースト、酵素、膨張剤などの添加配合量は、通常これらが焼菓子に配合される場合と同等であり、一般には約1重量%程度までである。 In addition, salt, yeast, an enzyme, a swelling agent, etc. can also be added to the baked confectionery of this invention as needed. Examples of the enzyme include various proteases, amylases, cellulases and the like that are generally well known for confectionery. Examples of the swelling agent include those commonly used in the food industry, such as sodium bicarbonate and ammonium bicarbonate, and those containing these. A typical example is a commercially available baking powder. The amount of these salt, yeast, enzyme, swelling agent and the like added is usually the same as when they are added to the baked confectionery, and is generally up to about 1% by weight.
本発明に係る焼菓子の製造方法においては、まず上記各成分を含有する生地を作成する。これは上記各成分の所定量を水と混合し、混合物を混練することにより行ない得る。上記各成分の混合、混練による生地の調製は、得られる生地が均一になるように適宜通常の装置、条件などを利用して行うことができる。例えばまず粉末状の各原料成分を秤量、混合し、混合粉末に水および水分を多く含む液状動物性たんぱく質素材(牛乳、全卵など)を混合する。この際、水および液状たんぱく質素材は予め約50℃程度に加温して用いることもでき、これによって得られる生地の温度を約30〜35℃程度に上げて生地を柔らかくして、引続く生地の成型を容易にすることができる。 In the method for producing a baked confectionery according to the present invention, a dough containing each of the above components is first prepared. This can be done by mixing a predetermined amount of each of the above components with water and kneading the mixture. Preparation of the dough by mixing and kneading each of the above components can be performed appropriately using ordinary equipment, conditions and the like so that the obtained dough becomes uniform. For example, first, powdery raw material components are weighed and mixed, and a liquid animal protein material (milk, whole egg, etc.) containing a lot of water and moisture is mixed into the mixed powder. At this time, the water and liquid protein material can be preheated to about 50 ° C., and the temperature of the resulting fabric is raised to about 30 to 35 ° C. to soften the fabric, and the subsequent fabric Can be easily formed.
本発明では、次いで上記で得られる生地を任意の形状に賦型する。この賦型は、通常の方法に従い、例えば、麺棒あるいは、デポジター、圧延ローラーなどの機械を用いて生地を伸ばし、型抜きして行う。その際の形状は任意のものとすることができる。製造の容易性、得られる食品の食べやすさなどを考慮すれば、通常、厚さ4〜8mm程度の板状体などとするのが望ましい。これら賦型物の大きさおよび長さは最終製品の食べ易さ、取扱いの容易さなどを考慮して適宜定めればよい。必要に応じ生地を裁断してもよい。 In the present invention, the dough obtained above is then shaped into an arbitrary shape. This shaping is performed according to a normal method, for example, using a rolling pin, a depositor, a rolling roller or the like to stretch the dough and perform die cutting. The shape at that time can be arbitrary. Considering the ease of production, the ease of eating the resulting food, etc., it is usually desirable to use a plate-like body having a thickness of about 4 to 8 mm. The size and length of these shaped products may be appropriately determined in consideration of the ease of eating and handling of the final product. The fabric may be cut as necessary.
本発明においては上記生地を加熱焼成することを不可欠とし、これによって、分岐鎖アミノ酸を含有する本発明の目的とする焼菓子形態の総合栄養食品を得ることができる。
加熱焼成の条件は、使用した原料素材、生地の水分含量などに応じて適宜選択でき、一般に製菓製造において採用されているそれらの条件と特に異なるものではない。通常、加熱温度範囲は約60〜250℃の範囲から選ばれ、加熱時間は約2〜60分の範囲から選ばれる。殊に好ましい温度および時間は約160〜220℃および8〜15分程度である。上記加熱焼成のための熱源としては、特に制約はなく熱水、蒸気、電気ヒーター、ガスオーブンなどの燃焼熱を利用するもの、電子レンジなどのマイクロ波、遠赤外線、赤外線などの各種のものを用いることができる。
In the present invention, it is indispensable to heat and bak the above-mentioned dough, whereby a baked confectionery-type comprehensive nutritional food containing the branched chain amino acid as the object of the present invention can be obtained.
The conditions for heating and baking can be appropriately selected according to the raw material used, the moisture content of the dough, and the like, and are not particularly different from those generally employed in confectionery production. Usually, the heating temperature range is selected from the range of about 60 to 250 ° C., and the heating time is selected from the range of about 2 to 60 minutes. Particularly preferred temperatures and times are about 160-220 ° C. and about 8-15 minutes. The heat source for the heating and firing is not particularly limited, and those using combustion heat such as hot water, steam, electric heaters, gas ovens, microwave ovens, microwaves, far infrared rays, infrared rays, etc. Can be used.
本発明の焼菓子の製造に際しては、上記に説明した組成範囲に基づいて、後述の実施例の方法や、焼菓子の製造法として従来から知られている方法、もしくは今後新しく提供される方法を利用することができる。 In the production of the baked confectionery of the present invention, based on the composition range described above, a method of Examples described later, a method conventionally known as a method for producing baked confectionery, or a method newly provided in the future Can be used.
本発明の焼菓子の保形性は、1.0〜1.15の範囲であることが好ましい。焼菓子の保形性が1.0より小さいと、焼菓子がボソボソとした食感になり、好ましくない。また、1.15を越えると、焼成後の焼菓子の形が悪くなり、好ましくない。 The shape retention of the baked confectionery of the present invention is preferably in the range of 1.0 to 1.15. If the shape retention of the baked confectionery is less than 1.0, the baked confectionery has a rough texture, which is not preferable. Moreover, when it exceeds 1.15, the shape of the baked confectionery after baking will worsen and it is not preferable.
本発明の焼菓子の焼成後の硬さは、20〜80 Nの範囲であることが好ましい。焼菓子の硬さが20 Nより小さいと、焼菓子が脆くなり、製造上好ましくない。また、80 Nを越えると硬くなりすぎ、食品として好ましくない。
It is preferable that the hardness after baking of the baked confectionery of this invention is the range of 20-80N. If the hardness of the baked confectionery is less than 20 N, the baked confectionery becomes brittle, which is not preferable in production. Moreover, when it exceeds 80 N, it will become hard too much and it is not preferable as a foodstuff.
次に、実施例を挙げて本発明をさらに詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Next, although an Example is given and this invention is demonstrated further in detail, this invention is not limited to these.
(実施例1)
表1に示す配合に基づき、調製法1の方法により焼菓子を得た。脂質エネルギー比は45%、分岐鎖アミノ酸は1.7g/100kcalになるように調整した。デンプン原料は、分岐鎖アミノ酸1重量部に対して0.8重量部配合した。得られた焼菓子について、評価法1および2に記載の方法で保形性および硬さを評価した。表3に示すように、得られた焼菓子の保形性は1.0、硬さは27Nであった。
(Example 1)
Based on the formulation shown in Table 1, baked confectionery was obtained by the method of Preparation Method 1. The lipid energy ratio was adjusted to 45%, and the branched chain amino acid was adjusted to 1.7 g / 100 kcal. The starch raw material was blended in an amount of 0.8 part by weight with respect to 1 part by weight of the branched chain amino acid. The obtained baked confectionery was evaluated for shape retention and hardness by the methods described in Evaluation Methods 1 and 2. As shown in Table 3, the obtained baked confectionery had a shape retention of 1.0 and a hardness of 27N.
(調製法1)
マーガリン(株式会社ADEKA)、グラニュー糖および乳化剤(サンソフトNo.818H、太陽化学株式会社)を4.8L容ステンレスボウルに入れ、ミキサー(KitchenAid 型式:KSM5、平面ビーター、株式会社エフ・エム・アイ)を用い、速度目盛り2で2分間ミキシングした。次に、凍結全卵(製菓用、キユーピータマゴ株式会社)を加えて、速度目盛り2で2分間ミキシングした。さらに、ミクロカルマグSおよびビタミンミックスを加えて、速度目盛り2で3分間ミキシングした後、ロイシン、イソロイシン、バリン(L−ロイシン、L−イソロイシン、L−バリン、いずれも協和発酵バイオ株式会社)、デンプン原料としてワキシーコーン由来のアルファ化デンプン(ワキシーアルファーY、三和澱粉工業株式会社)、濃縮大豆たんぱく(ARCON S、日本新薬株式会社)を加えて、速度目盛り1で30秒間、速度目盛り2で30秒間ミキシングした。最後に、小麦粉(日清フラワー薄力小麦粉、日清フーズ株式会社)を加えて、速度目盛り1で30秒間、速度目盛り2で1分間ミキシングして焼菓子用生地を調製した。得られた生地を麺棒で7mm厚の均一な板状に伸ばし、直径6cmの型により型抜きした。その後、型抜きした生地をオーブンレンジ(品番:NE−M250、松下電器産業株式会社)で170℃、14分間焼成し、焼菓子を得た。
(Preparation method 1)
Margarine (ADEKA Co., Ltd.), granulated sugar and emulsifier (Sunsoft No. 818H, Taiyo Kagaku Co., Ltd.) are placed in a 4.8 L stainless steel bowl, and a mixer (KitchenAid model: KSM5, flat beater, FMI Co., Ltd.) ) And mixing at speed scale 2 for 2 minutes. Next, frozen whole eggs (for confectionery, QP Corporation) were added and mixed for 2 minutes at a speed scale of 2. Furthermore, after adding microcalmag S and vitamin mix and mixing for 3 minutes at speed scale 2, leucine, isoleucine, valine (L-leucine, L-isoleucine, L-valine, all Kyowa Hakko Bio Co., Ltd.), starch Add waxy corn-derived pregelatinized starch (waxy alpha Y, Sanwa Starch Co., Ltd.) and concentrated soy protein (ARCON S, Nippon Shinyaku Co., Ltd.) as a raw material, 30 seconds on speed scale 1, 30 on speed scale 2 Mixing for 2 seconds. Finally, wheat flour (Nisshin Flour Wheat Flour, Nisshin Foods Co., Ltd.) was added and mixed at a speed scale 1 for 30 seconds and at a speed scale 2 for 1 minute to prepare a baked confectionery dough. The obtained dough was stretched into a uniform plate shape having a thickness of 7 mm with a rolling pin, and was cut out with a die having a diameter of 6 cm. Thereafter, the cut dough was baked at 170 ° C. for 14 minutes in an microwave oven (product number: NE-M250, Matsushita Electric Industrial Co., Ltd.) to obtain a baked confectionery.
(評価法1)
実施例1から7の焼菓子と比較例1から8の試料の保形性は、円盤状に成形された生地を上から見た場合の、焼成前の投影面積に対する焼成後の投影面積の比を画像解析ソフト(Scion Image、Scion Corporation)を用いてThreshold機能により閾値を設定し、2値化処理を行い、計測した。計測は、n=3で行い、結果は平均値で記した。結果を表3に示す。
(Evaluation method 1)
The shape retention of the baked confectionery of Examples 1 to 7 and the samples of Comparative Examples 1 to 8 is the ratio of the projected area after baking to the projected area before baking when the dough formed into a disk shape is viewed from above. A threshold value was set by the Threshold function using image analysis software (Scion Image, Scion Corporation), binarization processing was performed, and measurement was performed. The measurement was performed at n = 3, and the result was shown as an average value. The results are shown in Table 3.
(評価法2)
実施例1から7の焼菓子と比較例1から8の焼菓子の硬さは、焼成して得た焼菓子を、クリープメーター(MODEL RHEONER2、株式会社山電)を用いて、破断強度試験を行った場合の最大荷重を指標とした。感圧軸は、長さ3cm、幅1mmの楔形を用いて試験を行った。計測はn=5で行い、結果は平均値で示した。結果を表3に示す。
(Evaluation method 2)
The hardness of the baked confectionery of Examples 1 to 7 and Comparative Examples 1 to 8 was determined by performing a rupture strength test on the baked confectionery obtained by baking using a creep meter (MODEL RHEONER2, Yamaden Co., Ltd.). The maximum load when performed was used as an index. The pressure-sensitive shaft was tested using a wedge shape having a length of 3 cm and a width of 1 mm. The measurement was performed at n = 5, and the result was shown as an average value. The results are shown in Table 3.
(実施例2)
実施例1において、デンプン原料をタピオカ由来の酢酸デンプン、(タピオカアルファーTP−2、三和澱粉工業株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して焼菓子を得た。得られた焼菓子の保形性は1.01、硬さは25Nであった。結果を表3に示す。
(Example 2)
In Example 1, except that the starch raw material was changed to starch acetate derived from tapioca, (Tapioca alpha-TP-2, Sanwa Starch Co., Ltd.), the same preparation method as in Example 1 was repeated to obtain a baked confectionery. . The shape retention of the obtained baked confectionery was 1.01, and the hardness was 25N. The results are shown in Table 3.
(実施例3)
実施例1において、デンプン原料をもち米由来のアルファ化デンプン(モチールアルファー、上越スターチ株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して焼菓子を得た。得られた焼菓子の保形性は1.07、硬さは29Nであった。結果を表3に示す。
(Example 3)
In Example 1, a baked confectionery was obtained by repeating exactly the same preparation method as in Example 1, except that the starch raw material was changed to pregelatinized starch derived from glutinous rice (Motil Alpha, Joetsu Starch Co., Ltd.). The resulting baked confectionery had a shape retention of 1.07 and a hardness of 29N. The results are shown in Table 3.
(実施例4)
実施例1において、デンプン原料を馬鈴薯由来のヒドロキシプロピルリン酸架橋デンプン(エリアンVC120、松谷化学工業株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して焼菓子を得た。得られた焼菓子の保形性は1.0、硬さは29Nであった。結果を表3に示す。
Example 4
In Example 1, a baked confectionery was obtained by repeating exactly the same preparation method as in Example 1, except that the starch raw material was changed to potato-derived hydroxypropyl phosphate cross-linked starch (Elian VC120, Matsutani Chemical Co., Ltd.). The baked confectionery obtained had a shape retention of 1.0 and a hardness of 29N. The results are shown in Table 3.
(実施例5)
実施例1において、デンプン原料を小麦由来のアルファ化デンプン(小麦澱粉マル食、日本新薬株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.03、硬さは9Nであった。結果を表3に示す。
(Example 5)
In Example 1, a sample was obtained by repeating exactly the same preparation method as in Example 1 except that the starch raw material was changed to wheat-derived pregelatinized starch (wheat starch malt meal, Nippon Shinyaku Co., Ltd.). The obtained sample had a shape retention of 1.03 and a hardness of 9N. The results are shown in Table 3.
(実施例6)
実施例1において、デンプン原料をとうもろこしデンプン(日食コーンスターチY、日本食品化工株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.04、硬さは15Nであった。結果を表3に示す。
(Example 6)
In Example 1, a sample was obtained by repeating exactly the same preparation method as in Example 1, except that the starch raw material was changed to corn starch (eclipse corn starch Y, Nippon Shokuhin Kako Co., Ltd.). The obtained sample had a shape retention of 1.04 and a hardness of 15N. The results are shown in Table 3.
(比較例1)
実施例1において、デンプン原料をグラニュー糖に変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.16、硬さは17Nであった。結果を表3に示す。
(Comparative Example 1)
In Example 1, a sample was obtained by repeating exactly the same preparation method as in Example 1 except that the starch raw material was changed to granulated sugar. The obtained sample had a shape retention of 1.16 and a hardness of 17N. The results are shown in Table 3.
(比較例2)
実施例1において、デンプン原料をDE(分解度)11に調整されたタピオカデキストリン(パインデックス#2、松谷化学工業株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.18、硬さは18Nであった。結果を表3に示す。
(Comparative Example 2)
In Example 1, the same preparation method as in Example 1 was repeated except that the starch raw material was changed to tapioca dextrin (Paindex # 2, Matsutani Chemical Industry Co., Ltd.) adjusted to DE (decomposition degree) 11. Got. The obtained sample had a shape retention of 1.18 and a hardness of 18N. The results are shown in Table 3.
(比較例3)
実施例1において、デンプン原料をDE18に調製されたタピオカデキストリン(TK−16、松谷化学工業株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.19、硬さは25Nであった。結果を表3に示す。
(Comparative Example 3)
In Example 1, a sample was obtained by repeating exactly the same preparation method as in Example 1 except that the starch raw material was changed to tapioca dextrin (TK-16, Matsutani Chemical Industry Co., Ltd.) prepared in DE18. The obtained sample had a shape retention of 1.19 and a hardness of 25N. The results are shown in Table 3.
(比較例4)
実施例1において、デンプン原料をDE25のとうもろこしデキストリン(サンデック#250、三和澱粉工業株式会社)に変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.18、硬さは18Nであった。結果を表3に示す。
(Comparative Example 4)
A sample was obtained by repeating exactly the same preparation method as in Example 1, except that the starch raw material was changed to a corn dextrin of DE25 (Sandeck # 250, Sanwa Starch Co., Ltd.) in Example 1. The obtained sample had a shape retention of 1.18 and a hardness of 18N. The results are shown in Table 3.
(実施例7)
表3のようにマーガリンを150.00g、グラニュー糖を114.00g、デンプン原料としてワキシーアルファーYを6.00gに変えた以外は、実施例1と全く同じ調製法を繰り返して試料を得た。このとき、脂質エネルギー比は41%、分岐鎖アミノ酸は2.0g/100kcalになるように調製した。得られた試料の保形性は1.06、硬さは23Nであった。結果を表3に示す。
(Example 7)
As shown in Table 3, a sample was obtained by repeating exactly the same preparation method as Example 1, except that 150.00 g of margarine, 114.00 g of granulated sugar, and 6.00 g of waxy alpha-Y as a starch raw material were changed. At this time, the lipid energy ratio was adjusted to 41% and the branched chain amino acid was adjusted to 2.0 g / 100 kcal. The obtained sample had a shape retention of 1.06 and a hardness of 23N. The results are shown in Table 3.
(実施例8)
実施例7において、グラニュー糖を105.0g、ワキシーアルファーYを15.00gに変えた以外は、実施例7と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.0、硬さは27Nであった。結果を表4に示す。
(Example 8)
In Example 7, a sample was obtained by repeating exactly the same preparation method as in Example 7, except that 105.0 g of granulated sugar and 15.00 g of waxy alpha-Y were changed. The obtained sample had a shape retention of 1.0 and a hardness of 27N. The results are shown in Table 4.
(実施例9)
実施例7において、グラニュー糖を60.00g、ワキシーアルファーYを60.00gに変えた以外は、実施例7と全く同じ調製法を繰り返して試料を得た。得られた試料の保形性は1.0、硬さは42Nであった。結果を表4に示す。
Example 9
A sample was obtained by repeating exactly the same preparation method as in Example 7, except that in Example 7, granulated sugar was changed to 60.00 g and waxy alpha-Y was changed to 60.00 g. The obtained sample had a shape retention of 1.0 and a hardness of 42N. The results are shown in Table 4.
(比較例7)
実施例7において、グラニュー糖を120.00g、ワキシーアルファーYを無配合に変えた以外は、実施例7と全く同じ調整法を繰り返して試料を得た。得られた試料の保形性は、1.0、硬さは19Nであった。結果を表4に示す。
(Comparative Example 7)
In Example 7, a sample was obtained by repeating exactly the same adjustment method as in Example 7, except that 120.00 g of granulated sugar and waxy alpha-Y Y were changed to no formulation. The shape retention property of the obtained sample was 1.0, and the hardness was 19N. The results are shown in Table 4.
(比較例8)
実施例7において、グラニュー糖を39.90g、ワキシーアルファーYを80.00gに変えた以外は、実施例7と全く同じ調整法を繰り返したが、混練後の生地がまとまらず、引き続く圧延作業が不可能であった。
(Comparative Example 8)
In Example 7, the same adjustment method was repeated except that the granulated sugar was changed to 39.90 g and the waxy alpha-Y was changed to 80.00 g. However, the dough after kneading was not collected, and the subsequent rolling operation was continued. It was impossible.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011206430A JP5805477B2 (en) | 2011-09-21 | 2011-09-21 | Baked confectionery containing branched chain amino acids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011206430A JP5805477B2 (en) | 2011-09-21 | 2011-09-21 | Baked confectionery containing branched chain amino acids |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013066410A JP2013066410A (en) | 2013-04-18 |
JP5805477B2 true JP5805477B2 (en) | 2015-11-04 |
Family
ID=48472901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011206430A Active JP5805477B2 (en) | 2011-09-21 | 2011-09-21 | Baked confectionery containing branched chain amino acids |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5805477B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6601997B2 (en) * | 2014-04-02 | 2019-11-06 | 昭和産業株式会社 | Composition for bakery products |
WO2018131716A1 (en) * | 2017-01-16 | 2018-07-19 | 株式会社カネカ | Dough, baked confectionery, pharmaceutical composition and production method of these |
WO2018131717A1 (en) * | 2017-01-16 | 2018-07-19 | 株式会社カネカ | Dough, baked confectionery, pharmaceutical composition and production method of these |
JP7218097B2 (en) * | 2018-03-20 | 2023-02-06 | 株式会社ニップン | Mixed flour for baked confectionery, baked confectionery, and method for producing baked confectionery |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3599821B2 (en) * | 1995-03-29 | 2004-12-08 | 花王株式会社 | Cooking fats and oils |
JPH09224552A (en) * | 1996-02-23 | 1997-09-02 | Nisshin Flour Milling Co Ltd | Composition for cakes |
JPH11332514A (en) * | 1998-05-22 | 1999-12-07 | Nof Corp | Balanced nutritive food |
CN1747728A (en) * | 2003-01-10 | 2006-03-15 | 马斯特里赫特大学 | Compositions and methods for improving the condition of patients suffering from copd and other diseases |
JP2006109767A (en) * | 2004-10-15 | 2006-04-27 | Ezaki Glico Co Ltd | Method for producing pretzel |
JP5473701B2 (en) * | 2009-03-25 | 2014-04-16 | テルモ株式会社 | General nutrition food containing branched chain amino acids |
JP4733755B2 (en) * | 2009-04-04 | 2011-07-27 | 株式会社 伊藤園 | Baked confectionery with improved texture |
-
2011
- 2011-09-21 JP JP2011206430A patent/JP5805477B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013066410A (en) | 2013-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5473701B2 (en) | General nutrition food containing branched chain amino acids | |
EP2939542B1 (en) | Baked confectionery | |
RU2460303C1 (en) | Composition and method for production of oatmeal spice cakes with usage of preventive additive in arabinogalactan | |
RU2528463C1 (en) | Cookie | |
JP7364181B2 (en) | Composition for low-sugar confectionery and low-sugar confectionery using the same | |
US20100104707A1 (en) | Grain powder composition | |
JP5805477B2 (en) | Baked confectionery containing branched chain amino acids | |
WO2014156552A1 (en) | Soft cookie | |
US20040047962A1 (en) | Highly nutritious baked products | |
JP2016158608A (en) | Bakery food product composition | |
JP2006325471A (en) | Baked confectionery composition or baked confectionery | |
JP6129622B2 (en) | General nutrition food containing branched chain amino acids | |
WO2015060168A1 (en) | Food composition | |
JP2014008028A (en) | Food product for easy mastication and swallowing | |
JP2013102739A (en) | Baked confectionery containing branched amino acid | |
US20160100614A1 (en) | Natural binder derived from lipophilic pith fibers (ground stem or stalk internal fibers) separated from sunflower stems or stalks for processed foods and processed foods containing the same | |
JP2015142542A (en) | High protein pancake mix | |
JP4994336B2 (en) | Bread | |
JP6129623B2 (en) | General nutrition food containing branched chain amino acids | |
JP2017055710A (en) | Food product having improved odor of protein | |
JP2015092859A (en) | Branched-chain amino acid-containing comprehensive nutritional food | |
EP2982248A1 (en) | Soft cookie | |
JP6093276B2 (en) | Method for producing branched chain amino acid-containing comprehensive nutritional food | |
TW200913895A (en) | A method for producing baked foods | |
JP5593103B2 (en) | Amino acid-containing comprehensive nutritional food and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140807 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150430 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150602 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150710 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150804 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150902 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5805477 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |